Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Investing

Completion of Tranche 1 of the Placement

by admin December 20, 2024
December 20, 2024
Completion of Tranche 1 of the Placement

Cyprium Metals Limited (ASX: CYM, OTC: CYPMF) (Cyprium or the Company) is pleased to announce the successful completion of Tranche 1 of the two-tranche placement to raise in aggregate A$13.5 million (before costs) via the issue of a total of 483,203,140 fully paid ordinary shares in the Company (Placement Shares) at an issue price of A$0.028 per Share, as announced by the Company on 13 December 2024 (Placement).

Highlights:

  • Tranche 1 of the Placement raised A$5.2 million (before costs).
  • Completion of Tranche 2 of the Placement to raise an additional A$8.3 million is subject to shareholder approval at an extraordinary meeting to be held in January 2025.
  • Cyprium intends to undertake a retail entitlement offer to existing eligible shareholders on the same terms as the Placement.

Pursuant to the terms of the Placement, subscribers were offered 1 free-attaching unlisted option for every 2 Placement Shares subscribed for, with an exercise price of A$0.042 per option and expiry date of 31 December 2027 (Placement Options).

Under Tranche 1 of the Placement, the Company confirms that it has today issued:

  • 185,714,285 Placement Shares; and
  • 92,857,143 Placement Options.

Tranche 2 of the Placement, comprising 297,488,855 Placement Shares and 148,744,427 Placement Options will be issued subject to shareholder approval which will be sought at a meeting of the Company’s shareholders in January 2025. Shareholder approval is also being sought for the issue of 20,000,000 options on the same terms as the Placement Options to the cornerstone investor of the Placement.

Proceeds of the Placement will be used as follows:

  • Nifty site costs;
  • Permit support and DFS preparation and costs;
  • Tenement maintenance and geology work;
  • Working capital and costs of the Placement.

Canaccord Genuity acted as Lead Manager to the Placement.

Click here for the full ASX Release

This post appeared first on investingnews.com

previous post
Gold, Silver and Bitcoin Prices Fall as Fed Caps Off Year with Rate Cut
next post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

related articles

African Gold Announces Transformational Strategic Partnership with Montage...

March 25, 2025

Top 5 Small-cap Pharma Stocks of 2025

August 16, 2025

Blue Lagoon Completes Second Tranche of Private Placement...

March 18, 2025

Silver Price Update: Q1 2025 in Review

April 10, 2025

Top 5 Most-popular Uranium Stories of 2024

December 28, 2024

5 US States Mulling Bitcoin Reserves as Trump...

January 15, 2025

Further High-Grade Intercepts at Kamperman

March 24, 2025

December 2024 Quarterly Results Presentation

January 29, 2025

Brunswick Exploration Has Now Identified Four Major New...

July 9, 2025

Allied Critical Metals: Advancing Tungsten Projects in Portugal

June 21, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 2

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 3

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 4

      Lode Gold Launches Exploration Program at One of the Largest Land Packages in New Brunswick

      October 19, 2024
    • 5

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024

    Categories

    • Investing (2,599)
    • Latest News (2,300)
    • Politics (3,132)
    • Stocks (990)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved